Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
Coloplast A/S

Coloplast A/S (COLOB DC)

12
Analysis
Health CareDenmark
Coloplast A/S develops and provides health care products and services. The Company manufactures products for ostomy, incontinence, mastectomy, wound healing, and skin care. Coloplast's research projects are carried out in cooperation with professional caregivers and user groups. The Company sells to health care professionals, dealers, and product users throughout the world.
more
bullishColoplast A/S
11 Jul 2025 11:56

COLOPLAST - Why Recent Acquisitions Could Be the Catalyst for Explosive Growth!

Coloplast, a global leader in medical devices and solutions, has recently navigated a period of transition and strategic realignment as evidenced...

Logo
302 Views
Share
28 Apr 2023 16:37

Stay Tactically Overweight Defensives; Remain Overweight Europe, Japan, & EAFE. Buys in Defensives

$93 on $ACWI continues to be a key resistance that we have discussed since early-Jan as capping upside for 2023. Stick with defensives $IXJ $XLV...

Logo
512 Views
Share
bearishPolyNovo Ltd
26 Mar 2022 09:36

PolyNovo (PNV AU): Positive Momentum in U.S. Is Overshadowed by Cost Pressure and Lofty Valuation

PolyNovo’s continuing expansion of sales team and pipeline progress are pushing up the operating expenses, thereby increasing loss for the company....

Logo
422 Views
Share
bullishColoplast A/S
15 Nov 2021 09:28

Coloplast (COLOB DC): Adds Another Chronic Business Vertical; Recovering Base Business

Coloplast remains one of the most profitable medtech companies in Europe, with stable revenue growth. The company's acquisition of Atos Medical...

Logo
254 Views
Share
bullishAbbott India
12 Jul 2021 00:26

Global Equity Strategy: Mixed Market Environment Continues As Yields Break Down

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections and 10-year yields in the US and Germany are...

Logo
251 Views
Share
x